ALDURAZYME

Google image searchProduct monograph

Active ingredient

laronidase, 0.58 MG/ML

DIN: 02254506

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Schedule: Prescription / Schedule D

Company: SANOFI-AVENTIS CANADA INC

Date: 26-APR-2024

ATC:

• A16 — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD, )
• A16A — OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS (ATC, ATC/DDD)
• A16AB — Enzymes (ATC, ATC/DDD)
• A16AB05 — LARONIDASE (ATC/DDD)

Reference brand drug: Aldurazyme

External Links for Aldurazyme

Search on Google

• Aldurazyme side effects
• Aldurazyme dosage
• laronidase side effects
• laronidase dosage

Sanofi-Aventis Canada Inc

Go to Sanofi-Aventis website to see drug product details. Sometimes you can find aldurazyme photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.